| pubmed-article:7595738 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7595738 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:7595738 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:7595738 | lifeskim:mentions | umls-concept:C0543467 | lld:lifeskim |
| pubmed-article:7595738 | lifeskim:mentions | umls-concept:C0025202 | lld:lifeskim |
| pubmed-article:7595738 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:7595738 | lifeskim:mentions | umls-concept:C0021734 | lld:lifeskim |
| pubmed-article:7595738 | lifeskim:mentions | umls-concept:C1707391 | lld:lifeskim |
| pubmed-article:7595738 | lifeskim:mentions | umls-concept:C1522673 | lld:lifeskim |
| pubmed-article:7595738 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:7595738 | pubmed:dateCreated | 1995-12-15 | lld:pubmed |
| pubmed-article:7595738 | pubmed:abstractText | We conducted a randomized prospective trial in selected patients with fully resected high-risk stage I and II malignant melanoma. | lld:pubmed |
| pubmed-article:7595738 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595738 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595738 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595738 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7595738 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595738 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7595738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595738 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7595738 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:7595738 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:7595738 | pubmed:author | pubmed-author:KuglerJJ | lld:pubmed |
| pubmed-article:7595738 | pubmed:author | pubmed-author:AhmannD LDL | lld:pubmed |
| pubmed-article:7595738 | pubmed:author | pubmed-author:CreaganE TET | lld:pubmed |
| pubmed-article:7595738 | pubmed:author | pubmed-author:DaltonR JRJ | lld:pubmed |
| pubmed-article:7595738 | pubmed:author | pubmed-author:MortonR FRF | lld:pubmed |
| pubmed-article:7595738 | pubmed:author | pubmed-author:JungS HSH | lld:pubmed |
| pubmed-article:7595738 | pubmed:author | pubmed-author:LangdonR... | lld:pubmed |
| pubmed-article:7595738 | pubmed:author | pubmed-author:RodrigueL JLJ | lld:pubmed |
| pubmed-article:7595738 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7595738 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:7595738 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7595738 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7595738 | pubmed:pagination | 2776-83 | lld:pubmed |
| pubmed-article:7595738 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:meshHeading | pubmed-meshheading:7595738-... | lld:pubmed |
| pubmed-article:7595738 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7595738 | pubmed:articleTitle | Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma. | lld:pubmed |
| pubmed-article:7595738 | pubmed:affiliation | Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA. | lld:pubmed |
| pubmed-article:7595738 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7595738 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7595738 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:7595738 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:7595738 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7595738 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7595738 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7595738 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7595738 | lld:pubmed |
